Body Composition During Cancer Treatment

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
Cancer
Interventions
DEVICE

SOZO Device

SOZO device will estimate fluid status, total body composition, metabolic report, skeletal muscle mass, phase angle, body mass index, weight, and hydration index analysis. SOZO measurements will be performed before the start of cancer treatment, at the 1/4, 1/2, and 3/4 time points of treatment, and after completion of treatment. Participants be asked to fast for at least 8 hours before each visit, but water may be consumed to ensure they are well-hydrated. Participants will be asked to provide a urine sample at each visit and to report the color of your urine to the staff so they can determine how well hydrated the participants are. If not hydrated to the extent needed, participants will be asked to drink water and repeat the urine sample again after 30 minutes.

DEVICE

DEXA Scan

DEXA scan bone density reading with hip and spine measurements as well as a whole body composition scan will be performed. Where DEXA cannot be collected on the same day as other study assessments, Weight/BMI, Urine Color, and SOZO should all be collected (or repeated if already done) to coincide with the DEXA scan if SOZO is available at DEXA location.

Trial Locations (1)

29605

Prisma Health Cancer Institute Center for Integrative Oncology and Survivorship, Greenville

All Listed Sponsors
collaborator

ImpediMed Limited

INDUSTRY

lead

Prisma Health-Upstate

OTHER

NCT03784911 - Body Composition During Cancer Treatment | Biotech Hunter | Biotech Hunter